Saturday, August 12, 2017 8:45:55 AM
The lawsuit is just affording patient investors the opportunity to accumulate stock at very attractive prices.
I'd say the business is progressing well. Having a CFO in place now will allow the company to explore multiple options for financing. I'd expect the company to have a number of announcements through the end of the year. Signing a CFO with public markets experience and three new Board members to me is a great sign that the lawsuit isn't a big deal.
I think the company can do $0.04-$0.06 in EPS based on a 250mm share count over the next twelve months based on already announced contracts. The CEO has intimated that there is a lot of business just in Vietnam and the UAE that he can sign once more working capital is sourced.
Put a 10x multiple on that EPS figure and you get a 20-30 bagger from here.
As Buffett says, the market is a mechanism to transfer wealth from the impatient to the patient. I think this is a prime example.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM